• Submit Feedback on NIAID’s Research Framework for Antibacterial Resistance

    Virtual Event

    Submit Feedback on NIAID’s Research Framework for Antibacterial Resistance by March 8, 2019. NIAID is refining the five-year strategic framework for antibacterial resistance (AR) research and development, Antibacterial Resistance Program: Current Status and Future Directions pdf. Published in 2014, the framework identified the following priorities: Systems Biology and Antibacterial Resistance: New Directions for Drug Discovery Harnessing

  • Call for Reports: Evidence-Based Practices for Public Health Emergency Preparedness and Response

    Virtual Event

    Committee on Evidence - Based Practices for Public Health Emergency Preparedness and Response The National Academies of Sciences, Engineering, and Medicine s soliciting information to help inform the deliberations of a consensus study committee sponsored by the Centers for Disease Control and Prevention. The committee has been charged with conducting a comprehensive review and grading

  • Eureka Prize for Infectious Diseases Research

    Global Biodefense Calendar

    Entries are being accepted for the Eureka Prize for Infectious Diseases Research through 3 May 2019. Activity entered for this prize must have been undertaken in Australia or its territories (as defined by the Australian Government). For a team entry, the team leader must be either a) an Australian citizen, b) an Australian permanent resident,

  • RFI Deadline – Malaria Prophylactic Drug Tafenoquine

    Global Biodefense Calendar

    The U.S. Army Medical Research Acquisition Activity (USAMRAA) located at FT. Detrick, MD, has issued a solicitation outlining plans to conduct User Acceptance Testing for the malaria prophylactic drug (Tafenoquine) brand name Arakoda. The operational testing will look at the drug’s performance attributes and usability. The DoD is seeking sources, capability statements, and industry feedback

  • CDC RFI Deadline: Rapid Response to Outbreaks for Sample Collection

    Global Biodefense Calendar

    CDC is seeking information from companies and other organizations about their capability and capacity to deploy to the site of a domestic or international outbreak or public health emergency, obtain informed consent, collect specimens (blood, urine, swabs, etc.) from identified patients, and safely ship these specimens to CDC in accordance with all applicable local, state,

  • GHSA Supplemental Funding Opportunity Application Deadline – Ebola, Cholera Outbreak Response

    Global Biodefense Calendar

    CDC’s Emergency Response and Recovery Branch may have funds available to support emergency activities in response to the Ebola outbreak in the Democratic Republic of the Congo, the Rohingya refugee crisis in Bangladesh, and/or global cholera outbreak response. In response to the recent Ebola outbreak in West Africa, Emergency Response and Recovery Branch (ERRB) has

  • Estimated Release Date of Draft WHO Roadmap on Neglected Tropical Diseases 2012–2020

    Global Biodefense Calendar

    At its eleventh meeting in 2018, the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) recommended that WHO initiate a consultative process with the global NTD community to set new targets and milestones beyond 2020 to achieve the health-related 2030 United Nations Sustainable Development Goals (SDGs). Phase 1 feedback was collected, summarized and

  • Proposals Due: RNCP-Wide Dosimetry Guidance and Monitoring of Sources and Irradiation Protocols

    Global Biodefense Calendar

    NIAID is soliciting proposals to assess the current state of radiation dosimetry within the Radiation Nuclear Countermeasures Program to develop a consistent means of comparison and reproducibility across institutes. Consider submitting an offer if you can provide services, facilities, expertise, and capabilities needed to develop a centralized dosimetry harmonization effort. Ideally, you will have preliminary

  • Comments Due: 2019 Draft Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease

    Global Biodefense Calendar

    The Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR) are now accepting comments on the “2019 Draft Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease.” Feedback is sought not only from physicians and healthcare professionals, but also individuals affected by Lyme disease, such as